Men | Women | |||||
---|---|---|---|---|---|---|
Odds ratio (95% CI) | Odds ratio (95% CI) | |||||
n cases/controls | Crude | Adjusted | n cases/controls | Crude | Adjusted | |
Nested case-control study EPIC (1-SD)† | ||||||
log-UCB | 658/658 | 1.13 (1.00–1.28) | 1.19 (1.04–1.36) | 728/728 | 0.86 (0.77–0.97) | 0.86 (0.76–0.97) |
P | 0.05 | 0.01 | 0.01 | 0.02 | ||
MR approach for total bilirubin (1-SD)* | ||||||
rs6431625 Wald estimate§ | 28,270/22,204 | 1.07 (1.02–1.12) | 24,568/23,736 | 1.01 (0.96–1.06) | ||
P | 0.006 | 0.73 | ||||
114 SNPs likelihood-based MR estimate§ | 28,270/22,204 | 0.89 (0.80–1.00) | 24,568/23,736 | 1.00 (0.89–1.11) | ||
P | 0.05 | 0.96 |